허혈성 뇌졸중의 이차예방을 위한 항혈전제 치료

키워드

참고문헌 (45)

1. Mohan KM, "Risk and cumulative risk of stroke recurrence:a systematic review and meta-analysis", Stroke, 42, pp.1489~1494 (2011)
2. Antithrombotic Trialists’ Collaboration, "Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients", BMJ, 324, pp.71~86 (2002)
3. Algra A, "Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia", J Neurol Neurosurg Psychiatry, 60, pp.197~199 (1996)
4. "CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group", Lancet, 349, pp.1641~1649 (1997)
5. "The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group", Lancet, 349, pp.1569~1581 (1997)
6. Chen ZM, "Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups", Stroke, 31, pp.1240~1249 (2000)
7. Johnson ES, "A metaregression analysis of the dose-response effect of aspirin on stroke", Arch Intern Med, 159, pp.1248~1253 (1999)
8. Farrell B, "The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results", J Neurol Neurosurg Psychiatry, 54, pp.1044~1054 (1991)
9. Hansson L, "Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group", Lancet, 351, pp.1755~1762 (1998)
10. CAPRIE Steering Committee, "A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee", Lancet, 348, pp.1329~1339 (1996)
11. Ringleb PA, "Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events", Stroke, 35, pp.528~532 (2004)
12. Bhatt DL, "Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus", Am J Cardiol, 90, pp.625~628 (2002)
13. Bhatt DL, "Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery", Circulation, 103, pp.363~368 (2001)
14. 전성만, "급성기 뇌경색에서의 Clopidogrel의 저항성", 대한신경과학회지, 24(4), pp.319~323 (2006), 대한신경과학회
15. Matetzky S, "Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction", Circulation, 109, pp.3171~3175 (2004)
16. Gent M, "The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke", Lancet, 1, pp.1215~1220 (1989)
17. Hass WK, "A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group", N Engl J Med, 321, pp.501~507 (1989)
18. Fukuuchi Y, "A randomized, double-blind study comparing the safety and efficacy of clopidogrel versus ticlopidine in Japanese patients with noncardioembolic cerebral infarction", Cerebrovasc Dis, 25, pp.40~49 (2008)
19. Huang Y, "Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study", Lancet Neurol, 7, pp.494~499 (2008)
20. Shinohara Y, "Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial", Lancet Neurol, 9, pp.959~968 (2010)
21. Kamal AK, "Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin", Cochrane Database Syst Rev, pp.CD008076~ (2011)
22. Matías-Guiu J, "Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction:the TACIP Study: a randomized, double-blind, multicenter trial", Stroke, 34, pp.840~848 (2003)
23. Culebras A, "Triflusal vs aspirin for prevention of cerebral infarction: a randomized stroke study", Neurology, 62, pp.1073~1080 (2004)
24. Diener HC, "Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial", Lancet, 364, pp.331~337 (2004)
25. Bhatt DL, "Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events", N Engl J Med, 354, pp.1706~1717 (2006)
26. Benavente OR, "Effects of clopidogrel added to aspirin in patients with recent lacunar stroke", N Engl J Med, 367, pp.817~825 (2012)
27. Markus HS, "Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial", Circulation, 111, pp.2233~2240 (2005)
28. Wong KS, "Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial", Lancet Neurol, 9, pp.489~497 (2010)
29. Cardiogenic brain embolism, "The second report of the Cerebral Embolism Task Force", Arch Neurol, 46, pp.727~743 (1989)
30. Bogousslavsky J, "Cardiac sources of embolism and cerebral infarction--clinical consequences and vascular concomitants: the Lausanne Stroke Registry", Neurology, 41, pp.855~859 (1991)
31. Sandercock P, "Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project)", BMJ, 305, pp.1460~1465 (1992)
32. Hornig CR, "Cardioembolic stroke: results from three current stroke data banks", Neuroepidemiology, 13, pp.318~323 (1994)
33. "Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials", Arch Intern Med, 154, pp.1449~1457 (1994)
34. van Walraven C, "Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis", JAMA, 288, pp.2441~2448 (2002)
35. "Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group", Lancet, 342, pp.1255~1262 (1993)
36. Hylek EM, "An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation", N Engl J Med, 335, pp.540~546 (1996)
37. "Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial", Lancet, 348, pp.633~638 (1996)
38. "Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study", Lancet, 343, pp.687~691 (1994)
39. Gage BF, "Validation of clinical classification schemes for predicting stroke:results from the National Registry of Atrial Fibrillation", JAMA, 285, pp.2864~2870 (2001)
40. Furie KL, "Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association", American Stroke Association, 2012, pp.43, 3442~3453
41. Camm AJ, "2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association", Eur Heart J, 33, pp.2719~2747 (2012)
42. Connolly SJ, "Dabigatran versus warfarin in patients with atrial fibrillation", N Engl J Med, 361, pp.1139~1151 (2009)
43. Patel MR, "Rivaroxaban versus warfarin in nonvalvular atrial fibrillation", N Engl J Med, 365, pp.883~891 (2011)
44. Granger CB, "Apixaban versus warfarin in patients with atrial fibrillation", N Engl J Med, 365, pp.981~992 (2011)
45. Heidbuchel H, "European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation", Europace, 15, pp.625~651 (2013)

관련 논문AI추천